Recent observations indicate that cyclosporin A (CsA) blocks TCR initiated signal transduction and thus leads to abnormal TCR repertoire selection. CsA treatment can lead to overt autoimmune disease in two different experimental models. In both these models, the development of disease requires both the presence of autoreactive cells derived from the CsA treated thymus and an immunoregulatory abnormality in peripheral T cells. Preliminary data suggest that CsA inhibits thymic selection of the TCR2 (alphabeta TCR) repertoire, but not thymic maturation of the TCR1 (gammadelta TCR) sublineage. The broad, long-term objectives of these studies are to determine the physiologic function of these different T cell sublineages and to elucidate the nature of the peripheral immunoregulatory activity involved in tolerance.
The specific aims are to test three hypotheses. The first hypothesis is that CsA inhibits both positive and negative selection of the TCR2 repertoire in the thymus, but does not affect thymic TCR1 cell maturation. This hypothesis will be tested by determining the effect of CsA on thymic ontogeny utilizing a panel of mAb which recognize different TCRs and associated molecules. These studies will involve analysis of both murine and chicken T cell development. The focus will be on the selection of cells expressing particular Vbeta genes in the mouse and the maturation of the TCR3 subset, a novel alphabeta-like TCR, in the chicken. The second hypothesis is that the TCR1 repertoire is selected in peripheral tissue. This hypothesis will be tested by examination of the development and tissue homing pattern of TCR1 cells expressing particular Vgamma and Vdelta genes. Two experimental approaches will be used: 1) determining if CsA treatment results in inhibition of specific tissue homing patterns characteristic of TCR1 cells which utilize certain Vgamma genes. 2) intrathymic injection of FITC to identify recent thymic emigrants in peripheral tissues and the determining the pattern of Vgamma usage in these cells. The third hypothesis is that in models of CsA induced autoimmune disease, TCR2 cells mediate autoreactivity, while TCR1 cells regulate disease activity. Two different experimental models will studied: 1) neonatal CsA plus thymectomy and 2) lethally irradiated adults rescued with syngeneic BM transplant plus Ca treatment. These models will be established and the frequency and histologic localization of the different T cells sublineages will be characterized by immunohistochemical staining and FACS analysis. In both these models, the presence of """"""""normal"""""""" T cells blocks the ability of autoreactive T cells induce actual tissue lesions. The phenotype of both the autoreactive effector cells and the """"""""normal"""""""" regulatory cells will be determined using magnetic activated cell sorting and an adoptive transfer protocol.

Project Start
Project End
Budget Start
Budget End
Support Year
35
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Rundle, C H; Schroeder Jr, H W; Koopman, W J (1998) In situ hybridization analysis of immunoglobulin heavy chain variable gene expression with family specific oligonucleotide probes. J Immunol Methods 218:31-52
Su, X; Zhou, T; Yang, P et al. (1998) Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum 41:139-49
Clausen, B E; Bridges Jr, S L; Lavelle, J C et al. (1998) Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med 4:240-57
Fleck, M; Zhou, T; Tatsuta, T et al. (1998) Fas/Fas ligand signaling during gestational T cell development. J Immunol 160:3766-75
Johnson, M L; Keeton, L G; Zhu, Z B et al. (1997) Age-related changes in serum immunoglobulins in patients with familial IgA deficiency and common variable immunodeficiency (CVID). Clin Exp Immunol 108:477-83
Hsu, H C; Zhou, T; Yang, P A et al. (1997) Increased acute-phase response and renal amyloidosis in aged CD2-fas-transgenic mice. J Immunol 158:5988-96
Zhou, T; Fleck, M; Mueller-Ladner, U et al. (1997) Kinetics of Fas-induced apoptosis in thymic organ culture. J Clin Immunol 17:74-84
Cheng, J; Liu, C; Yang, P et al. (1997) Increased lymphocyte apoptosis in Fas ligand transgenic mice. J Immunol 159:674-84
Nishizaka, H; Horiuchi, T; Zhu, Z B et al. (1996) Genetic bases of human complement C7 deficiency. J Immunol 157:4239-43
Wu, J; Wilson, J; He, J et al. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98:1107-13

Showing the most recent 10 out of 105 publications